catechin has been researched along with Mesothelioma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, MC; Chen, CA; Chen, YL; Cheng, WF; Chiang, YC; Lin, HW; Sun, NY; Sun, WZ | 1 |
Burlando, B; Martinotti, S; Ranzato, E | 2 |
Biffo, S; Burlando, B; Gallo, S; Martinotti, S; Mutti, L; Ranzato, E; Russo, MV; Volta, V | 1 |
de Bari, L; Manente, GA; Moro, L; Mutti, L; Rossi, L; Vacca, RA; Valenti, D | 1 |
Burlando, B; Martinotti, S; Parodi, M; Ranzato, E; Vitale, M | 1 |
Biffo, S; Burlando, B; Magnelli, V; Martinotti, S; Murer, B; Mutti, L; Ranzato, E | 1 |
7 other study(ies) available for catechin and Mesothelioma
Article | Year |
---|---|
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Catechin; Cell Line, Tumor; Connective Tissue Growth Factor; Dendritic Cells; Drug Synergism; Female; GPI-Linked Proteins; Lung Neoplasms; Mesothelin; Mesothelioma; Mesothelioma, Malignant; Mice; Poly I-C; Treatment Outcome; Vaccines, DNA; Xenograft Model Antitumor Assays | 2018 |
(-)- Epigallocatechin-3-gallate induces GRP78 accumulation in the ER and shifts mesothelioma constitutive UPR into proapoptotic ER stress.
Topics: Apoptosis; Catechin; Cell Survival; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Homeostasis; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Molecular Chaperones | 2018 |
Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Inbred NOD; Mice, SCID; Pleural Neoplasms; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |
Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
Topics: Adenosine Triphosphate; Apoptosis; Catalase; Catechin; Cell Cycle; Cell Proliferation; Cells, Cultured; Cytochromes c; Electron Transport Complex I; Electron Transport Complex II; Epithelial Cells; Humans; Immunoblotting; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mitochondria; Mitochondrial Proton-Translocating ATPases; Oxidative Phosphorylation; Pleural Neoplasms; Reactive Oxygen Species; Superoxide Dismutase | 2013 |
Combination of ascorbate/epigallocatechin-3-gallate/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells.
Topics: Apoptosis; Ascorbic Acid; Catechin; Cell Cycle; Cell Line, Tumor; Deoxycytidine; Drug Combinations; Drug Synergism; Gemcitabine; Humans; Mesothelioma | 2014 |
In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Mesothelioma; Neutral Red | 2011 |
Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Calcium Channels, T-Type; Catalase; Catechin; Cell Death; Cell Line, Tumor; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Humans; Hydrogen Peroxide; Mesothelioma; Mibefradil; Pleura; Pleural Neoplasms; Reactive Oxygen Species | 2012 |